Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

Go back to Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
(NASDAQ: LABT) Delayed: 3.06 -0.35 (10.26%)
Previous Close $3.41    52 Week High
Open $3.55    52 Week Low
Day High $3.55    P/E N/A 
Day Low $2.77    EPS
Volume 2,050,032       

(NASDAQ: LABT) Delayed: 3.06 -0.35 (10.26%)
Previous Close $3.41    52 Week High
Open $3.55    52 Week Low
Day High $3.55    P/E N/A 
Day Low $2.77    EPS
Volume 2,050,032